16-30 of 182
Topical Cell-Free Therapy for Psoriasis: A Sponge-Based Secretome Formulation
Clinician's RoundtableTopical Cell-Free Therapy for Psoriasis: A Sponge-Based Secretome Formulation
Efgartigimod Shows Early Promise for Primary Sjögren’s Disease
Living RheumEfgartigimod Shows Early Promise for Primary Sjögren’s Disease
Unmasking Patient Subtypes in Sjögren’s Disease to Enable Personalized Care
Living RheumUnmasking Patient Subtypes in Sjögren’s Disease to Enable Personalized Care
Targeting Inflammation to Improve Gene Therapy Outcomes in Sickle Cell Disease
Clinician's RoundtableTargeting Inflammation to Improve Gene Therapy Outcomes in Sickle Cell Disease
FPIES in Infants: Optimizing Care and Addressing Complications
On the Frontlines of Food AllergiesFPIES in Infants: Optimizing Care and Addressing Complications
Care Considerations forIgE-Positive Food Protein-Induced Enterocolitis Syndrome
On the Frontlines of Food AllergiesCare Considerations forIgE-Positive Food Protein-Induced Enterocolitis Syndrome
- advertisement
Navigating Diagnostic Challenges in Food Protein-Induced Enterocolitis Syndrome
On the Frontlines of Food AllergiesNavigating Diagnostic Challenges in Food Protein-Induced Enterocolitis Syndrome
Moderna’s 2024–2025 COVID-19 Vaccine: Composition Updates and Interim Effectiveness Data
Clinician's RoundtableModerna’s 2024–2025 COVID-19 Vaccine: Composition Updates and Interim Effectiveness Data
Managing Food Allergies with Oral Immunotherapy: Benefits and Considerations
On the Frontlines of Food AllergiesManaging Food Allergies with Oral Immunotherapy: Benefits and Considerations
Assessing Milk and Egg Ladders for Pediatric IgE-Mediated Allergies
On the Frontlines of Food AllergiesAssessing Milk and Egg Ladders for Pediatric IgE-Mediated Allergies
An Analysis of Subcutaneous Versus Intravenous Atezolizumab in NSCLC
Spotlight On Subcutaneous Cancer ImmunotherapiesAn Analysis of Subcutaneous Versus Intravenous Atezolizumab in NSCLC
Nanrilkefusp Alfa: A Promising Subcutaneous IL-15Rβγ Superagonist
Spotlight On Subcutaneous Cancer ImmunotherapiesNanrilkefusp Alfa: A Promising Subcutaneous IL-15Rβγ Superagonist
- advertisement
Evaluating Alemtuzumab in Adult ALL: Insights from a Phase 1/2 Clinical Trial
Project Oncology®Evaluating Alemtuzumab in Adult ALL: Insights from a Phase 1/2 Clinical Trial
Insights on Food Allergy Anxiety: Understanding and Supporting Patients
On the Frontlines of Food AllergiesInsights on Food Allergy Anxiety: Understanding and Supporting Patients
Sublingual Immunotherapy for Peanut Allergy: The Value of Early Intervention
On the Frontlines of Food AllergiesSublingual Immunotherapy for Peanut Allergy: The Value of Early Intervention
